Literature DB >> 32779127

Cognitive Biases to Consider in Non-convulsive Status Epilepticus Presenting in a Hematologic Malignancy.

Katherine M Sawicka1,2, Derek MacFadden3, Victoria A McCredie4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32779127     DOI： 10.1007/s12028-020-01071-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN： 1541-6933            Impact factor:   3.210


× No keyword cloud information.
  6 in total

1.  West Nile virus meningoencephalitis: MR imaging findings.

Authors:  Kalliopi A Petropoulou; Steven M Gordon; Richard A Prayson; Paul M Ruggierri
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Pearls & oy-sters: bilateral thalamic involvement in West Nile virus encephalitis.

Authors:  James C Guth; Stephen A Futterer; Tarek A Hijaz; Eric M Liotta; Neil F Rosenberg; Andrew M Naidech; Matthew B Maas
Journal:  Neurology       Date:  2014-07-08       Impact factor: 9.910

Review 3.  West Nile virus neuroinvasive disease.

Authors:  Larry E Davis; Roberta DeBiasi; Diane E Goade; Kathleen Y Haaland; Jennifer A Harrington; JoAnn B Harnar; Steven A Pergam; Molly K King; B K DeMasters; Kenneth L Tyler
Journal:  Ann Neurol       Date:  2006-09       Impact factor: 10.422

4.  Characteristics and outcomes of patients with a haematological malignancy admitted to the intensive care unit for a neurological event.

Authors:  Martiene Riedijk; Walter M van den Bergh; Maarten van Vliet; Nuray Kusadasi; Lambert R F Span; Pieter R Tuinman; M Sesmu Arbous; Marcella C A Müller
Journal:  Crit Care Resusc       Date:  2015-12       Impact factor: 2.159

5.  West Nile encephalitis, status epilepticus and West Nile pneumonia in a renal transplant patient.

Authors:  Nitin Jain; David Fisk; Mark Sotir; Karen S Kehl
Journal:  Transpl Int       Date:  2007-07-13       Impact factor: 3.782

Review 6.  Clinical manifestations and outcomes of West Nile virus infection.

Authors:  James J Sejvar
Journal:  Viruses       Date:  2014-02-06       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.